AstraZeneca to discontinue Epanova trial, expects $100 mn writedown
The drug is already approved in the United States to reduce high levels of triglyceride in adult patients
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
AstraZeneca
AstraZeneca-Merck’s Lynparza wins approval in China for ovarian cancer treatment,
The approval in China is based on the results from a late-stage study in which Lynparza lowered the risk of disease progression or…
AstraZeneca’s Imfinzi gets FDA priority review for small cell lung cancer
The company said the FDA accepted its supplemental application and granted priority review to Imfinzi for the treatment of…
US FDA approves AstraZeneca’s diabetes drug for treating heart failure risk
The approval by the US Food and Drug Administration is based on results from the DECLARE-TIMI 58 clinical trial
We have unlocked the potential of data in the DMTA cycle
In this progressive world, where technology is leading the future, AstraZeneca has
partnered with Nasscom for incubating tech…
AstraZeneca India receives marketing permission for QTERN
Once-daily anti-diabetes treatment for adults with type-2 diabetes, QTERN combines two anti-hyperglycaemic agents with…
AstraZeneca lupus drug shows promise after set-back last year
The drug had failed to meet its main goal in the final stage of one of the two clinical trials under the TULIP programme last year…
US FDA grants orphan drug status to AstraZeneca’s asthma drug Fasenra
EoE, also known as allergic oesophagitis, is an allergic inflammation of the esophagus that involves a form of white blood cell,…
FDA gives fast track status to AstraZeneca’s diabetes drug Farxiga
In July, the US regulators had declined to approve Farxiga as a supplement to insulin in adults with type-1 diabetes where insulin…
AstraZeneca’s Farxiga meets main goal of heart failure study
Farxiga belongs to a class of medicines called SGLT2 inhibitors, which control blood sugar levels by causing the kidneys to expel…